Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab

Collapse authors list.
Pontes, Caridad, Zara, Corinne, Torrent-Farnell, Josep, Obach, Merce, Nadal, Cristina, Vella-Bonanno, Patricia, Ermisch, Michael, Simoens, Steven, Hauegen, Renata Curi, Gulbinovic, Jolanta et al (show 13 more authors) , Timoney, Angela, Martin, Antony P ORCID: 0000-0003-4383-6038, Mueller, Tanja, Nachtnebel, Anna, Campbell, Stephen, Selke, Gisbert, Bochenek, Tomasz, Rothe, Celia C, Mardare, Ileana, Bennie, Marion, Furst, Jurij, Malmstrom, Rickard E and Godman, Brian ORCID: 0000-0001-6539-6972 (2020) Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 18 (1). 5 - 16.

Text Pontes et al - accepted for publication.docx - Accepted Version Download (279kB)